First report of infections due to
Candidozyma
(formerly
Candida
)
auris
in Botswana, 2022-2024
Microbiol Spectr
.
2025 Oct 7;13(10):e0204225.
doi: 10.1128/spectrum.02042-25.
Epub 2025 Sep 3.
Authors
Teresia W Gatonye
1
2
,
Tichaona Machiya
3
,
Janet John-Thubuka
2
,
Jack Mkubwa
2
,
Tlhalefo D Ntereke
1
,
Tshiamo Zankere
1
,
Kwana Lechiile
1
,
Chimwemwe Viola Tembo
1
,
Boingotlo Gopolang
1
,
Kabelo Zwinila
2
,
Celda Tiroyakgosi
2
,
Naledi Mannathoko
3
,
Margaret Mokomane
3
,
Daniel Loeto
3
,
Miriam Mwamba
4
,
Rudzani Mashau
4
,
Ruth Mpembe
4
,
Silondiwe Nzimande
4
,
Nelesh P Govender
4
5
,
David M Goldfarb
6
,
Ebbing Lautenbach
7
,
Susan Coffin
7
8
,
Britt Nakstad
3
,
Jonathan Strysko
1
7
8
,
Melissa Richard-Greenblatt
9
10
Affiliations
1
Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.
2
Botswana Ministry of Health & Wellness, Gaborone, Botswana.
3
University of Botswana, Gaborone, Botswana.
4
National Institute for Communicable Diseases, Johannesburg, South Africa.
5
University of the Witwatersrand, Johannesburg, South Africa.
6
University of British Columbia, Vancouver, British Columbia, Canada.
7
University of Pennsylvania, Philadelphia, Pennsylvania, USA.
8
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
9
The Hospital for Sick Children, Toronto, Ontario, Canada.
10
University of Toronto, Toronto, Ontario, Canada.
PMID:
40900350
PMCID:
PMC12502547
DOI:
10.1128/spectrum.02042-25
No abstract available
Keywords:
Africa; Botswana; Candida auris; Candidozyma auris.
Publication types
Letter
Grants and funding
CDC-RFA-CK21-2106/CC/CDC HHS/United States